{
  "id": 6733,
  "url": "https://nnemf.org/research/6733-effects-of-low-level-light-therapy-on-streptozotocin",
  "title": "Effects of low-level light therapy on streptozotocin-induced diabetic kidney",
  "authors": [
    "Jinhwan Lim",
    "Ruth A Sanders",
    "Ann C Snyder",
    "Janis T Eells",
    "Diane S Henshel",
    "John B Watkins 3rd"
  ],
  "journal": "J Photochem Photobiol B",
  "year": "2010",
  "doi": "10.1016/j.jphotobiol.2010.03.002",
  "pmid": "20356759",
  "abstract": "Hyperglycemia causes oxidative damage in tissues prone to complications in diabetes. Low-level light therapy (LLLT) in the red to near infrared range (630-1000nm) has been shown to accelerate diabetic wound healing. To test the hypothesis that LLLT would attenuate oxidative renal damage in Type I diabetic rats, male Wistar rats were made diabetic with streptozotocin (50mg/kg, ip), and then exposed to 670nm light at a dose of 9J/cm(2) once per day for 14weeks. The activity and expression of catalase and the activity of Na K-ATPase increased in kidneys of light-treated diabetic rats, whereas the activity and expression of glutathione peroxidase and the expression of Na K-ATPase were unchanged. LLLT lowered the values of serum BUN, serum creatinine, and BUN/creatinine ratio. In addition, LLLT augmented the activity and expression of cytochrome c oxidase, a primary photoacceptor molecule in the mitochondrial respiratory chain, and reduced the formation of the DNA adduct 8-hydroxy-2'-deoxyguanosine in kidney. LLLT improved renal function and antioxidant defense capabilities in the kidney of Type I diabetic rats. Thus, 670nm LLLT may be broadly applicable to the amelioration of renal complications induced by diabetes that disrupt antioxidant defense mechanisms.",
  "effect": "benefit",
  "evidence": "low",
  "extraction": {
    "studyType": "animal",
    "studyTypeLabel": "Animal study",
    "effectDirection": "benefit",
    "evidenceLabel": "Low",
    "population": "Male Wistar rats with streptozotocin-induced Type I diabetes",
    "sampleSize": "—",
    "exposure": "optical (red/near-infrared) low-level light therapy (LLLT) · 9 J/cm^2 once per day for 14 weeks",
    "confidencePct": "74",
    "peerReviewed": "yes",
    "mainFindings": "Diabetic rats exposed to 670 nm light (9 J/cm^2 daily for 14 weeks) showed increased kidney catalase activity/expression and increased Na,K-ATPase activity, with no change reported for glutathione peroxidase activity/expression and Na,K-ATPase expression. Light therapy lowered serum BUN, serum creatinine, and the BUN/creatinine ratio, increased cytochrome c oxidase activity/expression, and reduced kidney 8-OHdG formation; authors conclude renal function and antioxidant defenses improved.",
    "outcomes": [
      "Kidney catalase activity and expression",
      "Kidney Na",
      "K-ATPase activity and expression",
      "Kidney glutathione peroxidase activity and expression",
      "Serum BUN",
      "Serum creatinine",
      "BUN/creatinine ratio",
      "Cytochrome c oxidase activity and expression",
      "Kidney 8-hydroxy-2'-deoxyguanosine (8-OHdG) DNA adduct formation",
      "Renal function",
      "Antioxidant defense in kidney"
    ],
    "limitations": [
      "Sample size not reported in provided abstract/metadata",
      "Animal model (streptozotocin-induced diabetic rats) may not generalize to humans",
      "Exposure parameters beyond wavelength",
      "dose",
      "and schedule (e.g.",
      "irradiance",
      "device details) not provided in abstract"
    ],
    "keywords": [
      "low-level light therapy",
      "LLLT",
      "670 nm",
      "near-infrared",
      "red light",
      "diabetes",
      "streptozotocin",
      "Type I diabetic rats",
      "kidney",
      "renal function",
      "oxidative damage",
      "catalase",
      "glutathione peroxidase",
      "Na",
      "K-ATPase",
      "cytochrome c oxidase",
      "8-hydroxy-2'-deoxyguanosine",
      "8-OHdG"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"animal\",\n  \"exposure\": {\n    \"band\": \"optical (red/near-infrared)\",\n    \"source\": \"low-level light therapy (LLLT)\",\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": \"9 J/cm^2 once per day for 14 weeks\"\n  },\n  \"population\": \"Male Wistar rats with streptozotocin-induced Type I diabetes\",\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"Kidney catalase activity and expression\",\n    \"Kidney Na,K-ATPase activity and expression\",\n    \"Kidney glutathione peroxidase activity and expression\",\n    \"Serum BUN\",\n    \"Serum creatinine\",\n    \"BUN/creatinine ratio\",\n    \"Cytochrome c oxidase activity and expression\",\n    \"Kidney 8-hydroxy-2'-deoxyguanosine (8-OHdG) DNA adduct formation\",\n    \"Renal function\",\n    \"Antioxidant defense in kidney\"\n  ],\n  \"main_findings\": \"Diabetic rats exposed to 670 nm light (9 J/cm^2 daily for 14 weeks) showed increased kidney catalase activity/expression and increased Na,K-ATPase activity, with no change reported for glutathione peroxidase activity/expression and Na,K-ATPase expression. Light therapy lowered serum BUN, serum creatinine, and the BUN/creatinine ratio, increased cytochrome c oxidase activity/expression, and reduced kidney 8-OHdG formation; authors conclude renal function and antioxidant defenses improved.\",\n  \"effect_direction\": \"benefit\",\n  \"limitations\": [\n    \"Sample size not reported in provided abstract/metadata\",\n    \"Animal model (streptozotocin-induced diabetic rats) may not generalize to humans\",\n    \"Exposure parameters beyond wavelength, dose, and schedule (e.g., irradiance, device details) not provided in abstract\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.74,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"low-level light therapy\",\n    \"LLLT\",\n    \"670 nm\",\n    \"near-infrared\",\n    \"red light\",\n    \"diabetes\",\n    \"streptozotocin\",\n    \"Type I diabetic rats\",\n    \"kidney\",\n    \"renal function\",\n    \"oxidative damage\",\n    \"catalase\",\n    \"glutathione peroxidase\",\n    \"Na,K-ATPase\",\n    \"cytochrome c oxidase\",\n    \"8-hydroxy-2'-deoxyguanosine\",\n    \"8-OHdG\"\n  ],\n  \"suggested_hubs\": []\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/20356759/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=6733",
  "updated": "2026-02-25 02:33:56"
}